Abstract Abstract and Key Results MNEs are moving away from a 'centralised hub'to a 'multi-
hub'network of R&D units. Using evidence from European pharmaceutical MNEs, this study …

It is possible that there once was a time when scholars used to sit isolated with their
cogitations in their attics, emerging now and then to publish their latest e-dite offerings which …

Several recent studies show European university scientists contributing far more frequently
to company-owned patented inventions than they do to patents owned by universities or by …

This paper addresses the conditions that enable new biotechnology firms (NBF) operating
outside major biotechnology clusters, to obtain the resources and competences necessary …

This paper examines the roles of international assignments and other forms of researcher
mobility inside the integrated R&D networks of six of the largest European pharmaceutical …

Developing technological applications, entering exploitation alliances, and choosing
between research‐or service‐focused strategic orientations are decisions that high‐tech …

International contributors provide the first examination of the growing subject of regional
knowledge-economy development. Illustrated by data and'stylized'accounts, the …

The aim of this research is to study the business models of the Italian biotechnological firms
through a statistical analysis, using the data base made up in the previous work by the same …

This paper analyzes whether there is a correspondence between a university's research
specialization and industrial specialization in the region hosting the university, and to what …

Breast cancer is one of the most commonly diagnosed cancers and a leading cause of death
for women worldwide. With advances in molecular engineering in the 1980s, hopes began …